# BioNTech SE: Form 20-F for the period ended Dec 31, 2019

- Company: [BioNTech SE](/companies/bntx.md) (CIK 1776985)
- Form: 20-F
- Filed: 2020-03-31
- Accepted by EDGAR: Mar 31, 2020, 16:10 ET
- Period: 2019-12-31
- Accession: 0001564590-20-014536
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1776985/000156459020014536/bntx-20f_20191231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1776985/000156459020014536/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2019-01-01 to 2019-12-31 | EUR 108.6m | ifrs-full:RevenueFromContractsWithCustomers |
| Cost of revenue | 12 months, 2019-01-01 to 2019-12-31 | EUR 17.4m | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2019-01-01 to 2019-12-31 | EUR 91.2m | ifrs-full:GrossProfit |
| Operating income | 12 months, 2019-01-01 to 2019-12-31 | −EUR 181.5m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2019-01-01 to 2019-12-31 | −EUR 268.0k | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2019-01-01 to 2019-12-31 | −EUR 179.1m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Operating cash flow | 12 months, 2019-01-01 to 2019-12-31 | −EUR 198.5m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2019-01-01 to 2019-12-31 | EUR 38.6m | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2019-12-31 | EUR 519.1m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2019-12-31 | EUR 560.2m | ifrs-full:CurrentAssets |
| Total assets | at 2019-12-31 | EUR 797.6m | ifrs-full:Assets |
| Current liabilities | at 2019-12-31 | EUR 138.1m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2019-12-31 | EUR 304.2m | ifrs-full:Liabilities |
| Shareholders' equity | at 2019-12-31 | EUR 493.5m | ifrs-full:EquityAttributableToOwnersOfParent |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1776985/000156459020014536/bntx-20f_20191231.htm

Filed Mar 31, 2020.
Source: SEC EDGAR, the filing index for accession 0001564590-20-014536. Last ingested by Listed: Nov 3, 2026, 08:40 ET. No prices; not investment advice.